Table 3 Clinical Trials involving tissue- and cell-based therapy approaches to promote fistula and tissue regeneration in the oropharynx
From: Regenerative medicine approaches for the management of respiratory tract fistulas
Condition | Intervention | ClinicalTrials.gov Identifier1 |
|---|---|---|
Tracheoesophageal fistula, bronchoesophageal fistula, tracheal fistula | Adipose-derived stromal vascular fraction for aero-digestive fistulae | NCT03792360 |
Bronchial fistula | Human amniotic epithelial cells for treatment of bronchial fistula | NCT02959333 |
Bronchopleural fistula | Umbilical cord mesenchymal stem cells for treatment of bronchopleural fistula | NCT02961725 |
Enterocutaneous fistula | Stromal vascular fraction for treatment of enterocutaneous fistula | NCT01584713 |
Dysphonia | Innovative treatment for scarred vocal cords by local injection of autologous stromal vascular fraction | NCT02622464 |
Vocal cord paralysis, unilateral | Injection laryngoplasty using autologous fat enriched with adipose-derived regenerative stem cells | NCT02904824 |
Hoarseness, dysphonia, aphonia, vocal fold; scar | A study of local administration of autologous bone marrow mesenchymal stromal cells in dysphonic patients with vocal fold scarring | NCT04290182 |
Vocal fold; scar | Pilot study of bone marrow stem cell treatment of patients with vocal fold scarring | NCT01981330 |